Immunomedics, Inc. (IMMU)
(Delayed Data from NSDQ)
$14.74 USD
-0.16 (-1.07%)
Updated May 3, 2019 04:00 PM ET
After-Market: $14.75 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[IMMU]
Reports for Purchase
Showing records 1 - 20 ( 68 total )
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Gilead Acquiring Immunomedics; Downgrading to Neutral; Raising PT to $88
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Trodelvy Hits Ground Running; 2Q20 Financials Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
AstraZeneca Takes Stake in Competitor TROP2-Targeted ADC; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Best Case Scenario Materializes With ASCENT Top-Line Data; Raising PT to $56
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Industry: Medical - Biomedical and Genetics
DS-1062 Clinical Data Update Appears Incrementally Positive for Trodelvy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
CEO Departure Does Not Sway Our Conviction on Trodelvy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
ASCO Abstracts Appear Incrementally Positive; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
1Q20 Financials Reported; Corporate Updates Provided; Lowering PT to $54
Provider: H.C. Wainwright & Co., Inc.
Analyst: BURNS R
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department